Key result
Lead extraction and balloon venoplasty resolve SVC syndrome, restoring QRS amplitude to enable S-ICD implantation.
Why the study?
Superior vena cava (SVC) syndrome is a rare complication of transvenous cardiac implantable electronic devices, but optimal management protocols remain undefined.
Case Report (n=1)
No
In patients with lead-associated SVC syndrome, treating the venous obstruction can alter QRS amplitude and potentially enable S-ICD eligibility.
Successful SVC syndrome treatment may restore S-ICD eligibility after lead extraction; single case leaves optimal strategies undefined.
Superior vena cava (SVC) syndrome is a rare complication associated with transvenous cardiac implantable electronic devices that may present with a variety of manifestations. Various strategies such as transvenous lead extraction, anticoagulation, venoplasty, and stenting have been used to treat this condition, but the optimal management protocols have yet to be defined. Subcutaneous implantable cardioverter-defibrillator (ICD) (S-ICD) therapy can be an alternative option to a transvenous system for those who require future ICD surveillance. We present a case of lead-associated SVC syndrome where thoracic venous congestion due to SVC obstruction influenced preimplant S-ICD QRS vector screening. Following treatment of venous obstruction, QRS amplitude may change and patients who were not initially S-ICD candidates may later become eligible.
No takes yet. Share an insight, caveat, or question.
Locke et al. (2021) conducted a case report in Lead-associated Superior Vena Cava Syndrome (n=1). Transvenous lead extraction and balloon venoplasty was evaluated. Transvenous lead extraction and balloon venoplasty successfully resolved lead-associated superior vena cava syndrome, restoring QRS amplitude and allowing for subsequent subcutaneous ICD implantation.